ContractopenMD
ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER
National Institutes of HealthDescription
ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER Recipient: AURO VACCINES LLC Award Amount: $10.73M
Requirements
Source: USASpending.gov
Interested in this contract?
Sign up to get match scores, track opportunities, and manage proposals with AI-powered tools.
Contract Details
Value Range
Up to $10,730,000
Deadline
December 31, 2026
Geographic Scope
MD
Status
open
External Links
View Original ListingSee how well this contract matches your organization.
Get Your Match Score